Biomedical applications of magnetic nanoparticles

Iron Oxides: Structure, Properties and Applications

Volumn , Issue , 2012, Pages 165-188

  Haddad, Paula Silvia ^a   Seabra, Amedea Barozzi ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug delivery; Iron oxide nanoparticles; Magnetic nanoparticles; Magnetic resonant imaging; Medical applications; Nanotechnology

Indexed keywords

EID: 84885139556     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (175)

1. Fang, B; Gon, S; Park, M; Kumar, KN; Rotello, VM; Nusslein, K; Santore, MM. Bacterial Adhesion on Hybrid Cationic Nanoparticle-Polymer Brush Surfaces: Ionic Strength Tunes Capture from Monovalent to Multivalent Binding. Colloids and Surfaces B: Biointerfaces, (2011), 87, 109-115.
2. Rosen, J E; Gu, FX. Surface Functionalization of Silica Nanoparticles with Cysteine: A Low-Fouling Zwitterionic Surface. Langmuir, (2011), 27, 10507-10513.
3. Brigger, I; Dubernet, C; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Delivery Rev., (2002), 54, 631-651.
4. Bonnemain, B. Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications -A review. J. Drug Target., (1998), 6, 167-174.
5. Shamsi, K; Balzer, T; Saini, S; Ros, PR; Nelson, RC; Carter, EC; Tollerfield, S; Niendorf, HP. Superparamagnetic iron oxide particles: Evaluation of efficacy in three doses for hepatic MR imaging. Radiology, (1998), 206, 365-371.
6. Ito, A; Shinkai, M; Honda, H; Kobayashi, T. Medical application of functionalized magnetic nanoparticles J. Biosci. Bioeng., (2005), 100, 1.
7. Pankhurst, QA; Connolly, J; Jones, SK; Dobson, J. Applications of magnetic nanoparticles in biomedicine J. Phys. D:Appl. Phys., (2003), 36, R167-R181.
8. Thomas, LA; Dekker, L; Kallumadil, M; Southern, P; Wilson, M; Nair, SP; Pankhurst, QA; Parkin, IP. Carboxylic acid-stabilised iron oxide nanoparticles for use in magnetic hyperthermia J. Mater. Chem., (2009), 19, 6529-6535.
9. Jeun, M; Bae, S; Tomitaka, A; Takemura, Y; Park, KH; Paek, SH; Chung, KW. Effects of particle dipole interaction on the ac magnetically induced heating characteristics of ferrite nanoparticles for hyperthermia Appl. Phys. Lett., (2009), 95, 2501-2503.
10. Pankhurst, QA; Thanh, NKT; Jones, SK; Dobson, J. Progress in applications of magnetic nanoparticles in biomedicine J. Phys. D: Appl. Phys., (2009), 42, 224001-224016.
11. Pankhurst, QA; Connolly, J; Jones, SK; Dobson, J. Applications of magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys., (2003), 36, R167-R181.
12. Jamieson, T; Bakhshi, R; Petrova, D; Pocock, R; Imani, M; Seifalian, AM. Biological applications of quantum dots Biomaterials, (2007), 28, 4717-4732.
13. Boisselier, E; Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity Chem. Soc. Rev., (2009), 38, 1759-1782.
14. Nguyen, TK; Thanha, L; Greena, AW. Functionalisation of nanoparticles for biomedical applications. Nano Today, (2010), 5, 213-230.
15. Dressman, D; Yan, H; Traverso, G; Kinzler, KW; Vogelstein, B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. PNAS, (2003), 100, 8817-8822.
16. Zigeuner, RE; Riesenberg, R; Pohla, H; Hofstetter, A; Oberneder, R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro J Urol., (2003), 169, 701-705.
17. Bulte, JWM; Kraitchman, DL. Iron oxide MR contrast agents for molecular and cellular imaging NMR Biomed, (2004), 17, 484-499.
18. Bean, CP; Jacobis, IS. Magnetic Granulometry and Superparamagnetism. J. Appl. Phys, (1956), 30, 1448-1452.
19. Cullity, BD. (1972). Introduction to Magnetic Materials, Addison-Wesley, Publishing Company Inc.
20. Morales, MP; Veintemillas-Verdaguer, S; Montero, MI; Serna, CJ; Roig, A; Casas, L; Martinez, B; Sandiumenge, F. Surface and internal spin canting in gamma-Fe2O3 nanoparticles Chem. Mater., (1999), 11, 3058-3064.
21. Batlle, X; Labarta, A. Finite-size effects in fine particles: magnetic and transport properties. J. Phys. D: Appl. Phys., (2002), 35, R15-R42.
22. Portet, D; Denizot, B; Rump, E; Lejeune, JJ; Jallet, P. Nonpolymeric coatings of iron oxide colloids for biological use as magnetic resonance imaging contrast agents. J. Colloid Interface Sci., (2001), 238, 37-42.
23. Tartaj, P; Morales, M; Veintemillas-Verdaguer, S; Gonźalez-Carreno, T; Serna, CJ. The preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys., (2003), 36, R182-R197.
24. Gubin, SP, (2009), Magnetic nanoparticles. 1aed. Wiley-VCH.
25. Cornell, RM; Scwertmann, U. (1996). The Iron Oxides, 1aed. Wiley-VCH.
26. Towe, KW; Bradley, WF. Mineralogical Constitution of Colloidal Hydrous Ferric Oxides. J. Coll. Int. Sci., (1967), 24, 384-392.
27. Chukhorv, FV. Mineralogical and Geochemical criteria in Genesis of Red Beds. Chem. Geol., (1973), 12, 67-75.
28. Machala, L; Tucek, J; Zboril, R. Polymorphous Transformations of Nanometric Iron(III) Oxide: A Review. Chem. Mater., (2001), 23(14), 3255-3272.
29. Braun, PB. A Superstructure in Spinels. Nature (London), (1952), 170, 1123-1123.
30. Rooymans, CJM. A New Type of Cation-Vacancy Ordering in the Spinel Lattice of In2S3. J. Inorg. Nucl. Chem., (1958), 181, 78-79.
31. Morales, MP; Pecharroman, C; Gonzalez-Carreno; Serna, SJ. Structural Characteristics of Uniform Gamma Fe2O3 Particles with Different Axial (Length/Width) Ratios. J. Solid State Chem., (1994), 108, 158-163.
32. Shafi, KV; Ulman, A; Dyal, A; Yan, XY; Yang, NL; Estournes, C; Fournes, L; Wattiaux, A; White, H; Rafailovich, M. Magnetic enhancement of gamma-Fe2O3 nanoparticles by sonochemical coating. Chem. Mater., (2002), 14, 1778-1787.
33. Kelm, K; Mader, WZ. The symmetry of ordered cubic gamma-Fe2O3 investigated by TEM Naturforsch. B, (2006), 61, 665-671.
34. Jorgensen, JE; Mosegaard, L; Thomsen, LE; Jensen, TR; Hanson, JCJ. Formation of gamma-Fe2O3 nanoparticles and vacancy ordering: An in situ X-ray powder diffraction study. Solid State Chem., (2007), 180, 180-185.
35. Khollam, YB; Dhage, SR; Potdar, HS; Deshpande, SB; Bakare, PP; Date, DK. Microwave hydrothermal preparation of submicron-sized spherical magnetite (Fe3O4)powders Mat. Lett., (2002), 56, 571-577.
36. Liz, L; Quintela, MAL; Mira, J; Rivas, J. Preparation of Colloidal Fe3O4 Ultrafine Particles Microemulsions. J. Mat. Scien., (1994), 29, 3797-3801.
37. Balasubramaniam, C; Khollam, YB; Banerjee, I; Bakare, PP; Date, SK; Das, AK; Bhoraskar, SV. DC thermal arc-plasma preparation of nanometric and stoichiometric spherical magnetite (Fe3O4) powders. Mat. Lett., (2004), 58, 3958-3962.
38. Ni, Y; Ge, X; Zhang, Z; Ye, Q. Fabrication and characterization of the plate-shaped gamma-Fe2O3 nanocrystals. Chem. Mat., (2002), 14, 1048-1052.
39. Bhattacharjee, A; Mandal, H; Roy, M, Kusz, J; Hofmeister, W. Microstructural and magnetic characterization of fly ash from Kolaghat Thermal Power Plant in West Bengal, India J. of Magn. and Magn. Mat., (2001), 323, 3007-3012.
40. Lima Jr, E; De Biasi, E; Vasquez Mansilla, M; Saleta, ME; Effenberg, F; Rossi, LM; Cohen, R; Rechenberg, HR; Zysler, RD. Surface effects in the magnetic properties of crystalline 3 nm ferrite nanoparticles chemically synthesized. J. Appl. Phys., (2010), 108, 103919-103929.
41. Lamer, VK; Dinegar, RH. Theory, Production and Mechanism of Formation of Monodispersed Hydrosols. J. Am. Chem. Soc., (1950), 72, 4847-4854.
42. Souza, EA; Winnischofer, H; Haddad, P; Costa, TCR; Zanchet, D. Effects of Particles Size and Shynthesis Temperature on the Structural Properties of the Ni Nanoparticles: Insights about the Formation of the fcc-Ni structure. AIP Conf. Proc., (2009), 1092, 135-137.
43. Sun, S; Zeng, H; Robinson, DB; Raoux, S; Rice, PM; Wang, SX; Li, G. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc., (2004), 126, 273-279.
44. Laurent, S; Forge, D; Port, M; Roch, A; Robic, C; Elst, LV; Muller, RN. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev., (2008), 108, 2064-2110.
45. Haddad, PS; Duarte, EL; Baptista, MS; Goya, GF; Leite, CAP; Itri, R. Shynthesis and Characterization of Silica-Coated Magnetic Nanoparticles. Prog. Colloid. Polym. Sci, (2004), 128, 232-238.
46. Jiang, WQ; Yang, HC; Yang, SY; Horng, HE; Hung, JC; Chen, YC; Hong, CY. Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible J. Magn. Magn. Mater., (2004), 283, 210-214.
47. Dacoata, GM; Degrave, E; Debakker, PMA; Vandenberghe, RE. Synthesis and Characterization of Some Iron-Oxides by Sol-Gel Method. J. Solid State Chem., (1994), 113, 405-412.
48. Deng, Y.; Wang, L.; Yang, W.; Fu, S.; Elaissari, A. Preparation of magnetic polymeric particles via inverse microemulsion polymerization process. J. Magn. Magn. Mater., (2003), 257, 69-78.
49. Abu Mukh-Qasem, R; Gedanken, A. Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles. J. Colloid Interface Sci., (2005), 284, 489-494.
50. Chen, D; Xu, R. Hydrothermal synthesis and characterization of nanocrystalline Fe3O4 powders Mater. Res. Bull., (1998), 33, 1015-1021.
51. Hyeon, T; Lee, SS; Park, J; Chung, Y; Na, HB. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J. Am. Chem. Soc., (2001), 123, 12798-12801.
52. Haddad, PS; Rocha, TR; Souza, ER; Martins, TM; Knobel, M; Zanchet, D. Interplay between crystallization and particle growth during the isothermal annealing of colloidal iron oxide nanoparticles. J. Colloid Inter. Sci., (2009), 339, 344-350.
53. Park, S; Lee, H; Goo, S; Hun, SK. Thermal Decomposition Behavior of Carbon Nanotube Reinforced Thermotropic Liquid Crystalline Polymers. J. Apll. Polym. Scien., (2011), 122, 2060-2070.
54. De Biasi, E; Ponce de León, A; Nunes, WC; Haddad, PS; Rocha, TR; Duque, JGS; Zanchet, D; Knobel, M. Complex magnetic internal order in structurally disordered Ni nanoparticles. Eur. Phys. J. B,(2008), 66, 503-508.
55. Basak, S; Chen, DR; Biswas, P. Electrospray of ionic precursor solutions to synthesize iron oxide nanoparticles: Modified scaling law Chem. Eng. Sci., (2007), 62, 1263-1268.
56. Veintemillas-Verdaguer, S; Morales, MP; Serna, CJ. Continuous production of gamma-Fe2O3 ultrafine powders by laser pyrolysis. Mater. Lett., (1998), 35, 227-231.
57. Gnanaprakash, G; Mahadevan, S; Jayakumar, T; Kalyanasundaram, P; Philip, J; Raj, B. Effect of initial pH and temperature of iron salt solutions on formation of magnetite nanoparticles Mater. Chem. Phys., (2007), 103, 168-175.
58. Ozin, GA; Arsenault, AC, (2005). Nanochemistry: A Chemistry Approach to Nanomaterials, RSC Publishing, Cambridge.
59. Sweeney, SF; Woehrle, GH; Hutchison, JE. Rapid purification and size separation of gold nanoparticles via diafiltration J. Am. Chem. Soc., (2006), 128, 3190-3197.
60. Gnanaprakash, G; Philip, J; Jayakumar, T; Raj, B. Effect of digestion time and alkali addition rate on physical properties of magnetite nanoparticles. J. Phys. Chem. B, (2007), 111, 7978-7986.
61. Park, HS; Dodbiba, G; Cao, LF; Fujita, T. Synthesis of silica-coated ferromagnetic fine powder by heterocoagulation. J. Phys.: Condens. Mater., (2008), 20, 204105-204105.
62. Bagaria, HG; Johnson, DT; Srivastava, C; Thompson, GB; Shamsuzzoha, M; Nikles, DE. Formation of FePt nanoparticles by organometallic synthesis. J. Appl. Phys., (2007), 101, 104313-104318.
63. Salavati-Niasari, M; Khanson, A; Davar, F. Synthesis and characterization of cobalt oxide nanoparticles by thermal treatment process. Inorg. Chim. Acta, (2009), 362, 4937-4942.
64. Chen, YZ; Luo, XH; She, HD; Yue, GH; Peng, DL. Size-and Structure-Controlled Synthesis and Characterization of Nickel Nanoparticles. J. Nanosci. Nanotechnol., (2009), 9, 5157-5163
65. Murray, CB; Norris, DJ; Bawendi, MG. Synthesis and Characterization of Nearly Monodisperse CDE (E = S, Se, Te) semiconductor nanocrystallites. J. Am. Chem. Soc., (1993), 115, 8706-8715.
66. Vargas, JM; Socolovsky, LM; Goya, GF; Knobel, M; Zanchet, D. Structural, magnetic, and Mossbauer characterization of size-controlled iron-iron oxide nanoparticles obtained by chemical methods. IEEE Trans. Magn., (2003), 39, 2681-2683.
67. Sun, S; Zeng, H. Size-controlled synthesis of magnetite nanoparticles. J. Am. Chem. Soc., (2002), 124, 8204-8205.
68. Park, J; An, KJ; Hwang, YS; Park, JG; Noh, HJ; Kim, JY; Park, JH; Hwang, NM; Hyeon, T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater, (2004), 3, 891-895.
69. Hao, R; Xing, R; Xu, Z; Hou, Y; Gao, S; Sun, S. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Adv. Mater., (2010), 22, 2729-2742.
70. Xu, Z; Shen, C; Hou, Y; Gao, H; Sun, S. Oleylamine as Both Reducing Agent and Stabilizer in a Facile Synthesis of Magnetite Nanoparticles. Chem. Mater., (2009), 21, 1778-1780.
71. Hou, Y; Xu, Z; Sun, S. Controlled synthesis and chemical conversions of FeO nanoparticles. Angew. Chem. Int. Ed., (2007), 46, 6329-6332.
72. Cao, HM; Huang, GJ; Xuan, SF; Wu, QF; Gu, F; Li, CZ. Synthesis and characterization of carbon-coated iron core/shell nanostructures. J. Alloys Compounds., (2008), 448, 272-276.
73. Chakka, VM; Altuncevahir, B; Jin, ZQ; Li, Y; Liu, JP. Magnetic nanoparticles produced by surfactant-assisted ball milling. J. Appl. Phys., (2006), 99, 08E912-08E915.
74. Wang, XD; Egan, CE; Zhou, MF; Prince, K; Mitchell, DRG; Caruso, RA. Effective gel for gold nanoparticle formation, support and metal oxide templating. Chem. Commun, (2007), 29, 3060-3062.
75. Lin, SY; Chen, NT; Sum, SP; Lo, LW; Yang, CS. Ligand exchanged photoluminescent gold quantum dots functionalized with leading peptides for nuclear targeting and intracellular imaging. Chem. Commun., (2008), 39, 4762-4764.
76. Chan, WCW; Nie, SM. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science, (1998), 281, 2016-2018.
77. Abad, JM; Mertens, SFL; Pita, M; Fernandez, VM; Schiffrin, DJ. Functionalization of thioctic acid-capped gold nanoparticles for specific immobilization of histidine-tagged proteins. J. Am. Chem. Soc., (2005), 127, 5689-5694.
78. Huh, YM; Jun, YW; Song, HT; Kim, S; Choi, JS; Lee, JH. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J. Am. Chem. Soc., 127, (2005), 12387-12391.
79. Klotz, M; Ayral, A; Guizard, C; Ménae, C; Cabuil, V. Silica coating on colloidal maghemite particles. J. Colloid Interface Sci, (1999), 220, 357-261.
80. Ma, M; Zhang, Y; Yu, W; Shenm, HY; Zhang, HQ; Gu, N. Preparation and characterization of magnetite nanoparticles coated by amino silane. Colloids Surf. A, (2003), 212, 219-226.
81. Kim, J; Lee, JE; Lee, J; Yu, JH; Kim, BC; An, K, Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc., (2006), 128, 688-689.
82. Morales, MP; Munoz-Aguado, MJ; Garcia-Palacio, JL; Lazaro, FJ; Serna, CJ. Coercivity enhancement in gamma-Fe2O3 particles dispersed at low-volume fraction J. Magn. Magn. Mater, (1998), 183, 232-240.
83. Moreno, EM; Zayat, M; Morales, MP; Serna, CJ; Roig, A; Levy, D. Preparation of narrow size distribution superparamagnetic gamma-Fe2O3 nanoparticles in a sol-gel transparent SiO2 matrix. Langmuir, (2002), 18, 4972-4978.
84. Klichko, Y; Liong, M; Choi, E; Angelos, S; Nel, AE; Stoddart, JE; Tamanoi, F; Zink, JI. Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery. J. Am. Ceram. Soc., (2009), 92, S2-S10.
85. Mulder, WJM; Strijkers, GJ; Tilborg, GAF; Cormode, DP; Fayad, ZA; Nicolay, K. Nanoparticulate Assemblies of Amphiphiles and Diagnostically Active Materials for Multimodality Imaging. Acc. Chem. Res., (2009), 42, 904-914.
86. Piao, Y; Burns, A; Kim, J; Wiesner, U; Hyeon, T. Designed Fabrication of Silica-Based Nanostructured Particle Systems for Nanomedicine Applications. Adv. Funct. Mater., (2008), 18, 3745-3758.
87. Slowing, II; Vivero-Escoto, JL; Wu, CW; Lin, VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Delivery Rev., (2008), 60, 1278-1288.
88. Park, K; Liang, G; Ji, XJ; Luo, ZP; Li, C; Croft, MC; Markert, JT. Structural and magnetic properties of gold and silica doubly coated gamma-Fe2O3 nanoparticles. J. Phys. Chem. C, (2007), 111, 18512-18519.
89. Ma, DL; Guan, JW; Normandin, F; Dénommée, S; Enright, G; Veres, T; Simard, B. Multifunctional nano-architecture for biomedical applications. Chem. Mater., (2006), 18, 1920-1927.
90. Cannas, C; Casula, MF; Concas, G; Corrias, A; Gatteschi, D; Falqui, A; Musinu, A; Sangregorio, C; Spano, G. Magnetic properties of gamma-Fe2O3-SiO2 aerogel and xerogel nanocomposite materials. J. Mater. Chem., (2001), 3180-3187.
91. Cannas, C; Gatteschi, D; Musinu, A; Piccaluga, G; Sangregorio, C. Structural and magnetic properties of Fe2O3 nanoparticles dispersed over a silica matrix. J. Phys. Chem B, (1998), 102, 7721-7726.
92. E. Yaghini; A.M. Seifalian; A.J. MacRobert, Nanomedicine, 4, (2009) 353.
93. Rodrigues, MA; Tada, DB; Politi, MJ; Baptista, MS. Photophysical and photochemical properties of porphyrin and naphthalene diimide modified silica-gel particles. J. Non. Cryst. Solids, (2002), 304, 116-125.
94. Rodrigues, MA; Politi, MJ; Bemquerer, MTM; Brochsztain, S; Baptista, MS. Porphyrin and naphtalenediimide functionalized silica-gel particles. Photophysical properties. Chem. Lett., (2002), 6, 604-605.
95. Xu, B; Dou, H; Tao, K; Sun, K; Ding, J; Shi, W; Guo, X; Li, J; Zhang, D; Sun, K. Two-in-One" Fabrication of Fe(3)O(4)/MePEG-PLA Composite Nanocapsules as a Potential Ultrasonic/MRI Dual Contrast Agent. Langmuir, (2011), 27, 12134-12142.
96. Xiao, L; Li, J; Dermot, B. Water-Soluble Superparamagnetic Magnetite Nanoparticles with Biocompatible Coating for Enhanced Magnetic Resonance Imaging. ACS Nano, (2011), 5, 6315-6324.
97. Balasubramaniam, S; Pothayee, N; Lin, Y; House, M; Woodward, RC; St. Pierre, TG; Davis, RM; Riffle, JS. Poly(N-isopropylacrylamide)-Coated Superparamagnetic Iron Oxide Nanoparticles: Relaxometric and Fluorescence Behavior Correlate to Temperature-Dependent Aggregation. Chem. Mater., (2011), 23, 3348-3356.
98. Sancho, NM; Miguel, OB; Colom, G; Salvador, JP; Marco, MP; Santamari, J. Development of Stable, Water-Dispersible, and Biofunctionalizable Superparamagnetic Iron Oxide Nanoparticles. Chem. Mater., (2011), 23, 2795-2802.
99. Jennings, LE; Long, NJ. Two is better than one'-probes for dual-modality molecular imaging Chem. Commun., (2009), 3511-3524.
100. Yulei, C; Xinlei, M; Yili, Z. Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). J. Colloid Interface Sc., (2011), 363, 403-409.
101. Na, HB; Song, IC; Hyeon, T. Inorganic Nanoparticles for MRI Contrast Agents. Adv. Mater., (2009), 21, 2133-2148.
102. Song, H; Choi, J; Huh, Y; Kim, S; Jun, Y; Suh, J; Cheon, J. Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J. Am. Chem. Soc., (2005), 127, 9992-9993.
103. Pellegrino, T; Kudera, S; Liedl, T; Javier, AM; Manna, L; Parak, WJ. On the development of colloidal nanoparticles towards multifunctional structures and their possible use for biological applications. Small, (2005), 1, 48-63.
104. Weissleder, R; Cheng, H; Bogdanova, A; Bogdanov Jr., A. Magnetically labeled cells can be detected by MR imaging. J. Magn. Reson. Imag., (1997), 7, 258-263.
105. Roch, A; Muller, RN; Gillis, P. Theory of proton relaxation induced by superparamagnetic particles. J. Chem. Phys., (1999), 110, 5403-5411.
106. Bulte, JWM; Brooks, RA; Moskowitz, BM; Bryant Jr., LH; Frank, JA. Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn. Res. Med. 42, (1999), 379-384.
107. Lee, JH; Huh, YM; Jun, Y; Seo, J; Jang, J; Song, HT; Kim, S; Cho, EJ; Yoon, HG; Suh, JS; Cheon, J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med., (2007), 13, 95-99.
108. Qiang, Y; Antony, J; Sharma, A; Nutting, J; Sikes, D; Meyer, D. Iron/iron oxide core-shell nanoclusters for biomedical applications. J. of Nanopart. Res., (2006), 8, 489-496.
109. Brust, M; Walker, M; Bethell, D; Schiffrin, DJ; Whyman, R. Synthesis of Thiol-Derivatized Gold Nanoparticles in a 2-phase liquid-liquid System. J. Chem. Soc., Chem. Commun., (1994), 801-802.
110. Larson, TA; Bankson, J; Aaron, J; Sokolov, K. Hybrid plasmonic magnetic nanoparticles as molecular specific agents for MRI/optical imaging and photothermal therapy of cancer cells. Nanotech., (2007), 18, 325101-325105.
111. Kousaku, M; Koji, K; Takanori, M; Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR-and HER2-overexpressing esophageal cancer cell lines. Int., J of Cancer., (2011), 129, 2408-2416.
112. Hu, FQ; Wei, L; Zhou, Z; Ran, YL; Li, Z; Gao, MY. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Adv. Mater., (2006), 18, 2553-2556.
113. Tzu-Chao, C; Chung, HS; Yi-Ting, C. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Cancer Lett. (2011), 311, 11-19.
114. Matsumura, Y. Polymeric Micellar Delivery Systems in Oncology. Jpn. J. Clin. Oncol., (2008), 38, 793-802.
115. Aliabadi, HM; Shahin, M; Brocks, DR; Lavasanifiar, A. Disposition of drugs in block copolymer micelle delivery systems -From discovery to recovery. Clin. Pharmacokinet., (2008), 47, 619-634.
116. Yokoyama, M. Flux characteristics of cell culture medium in rectangular microchannels J. Artif. Organs., (2011), 8, 238-244.
117. Uhrich, KE; Cannizzaro, SM; Langer, RS; Shakesheff, KM. Polymeric systems for controlled drug release. Chem. Rev., (1999), 99, 3181-3198.
118. Soussan, E; Cassel, S; Blanzat, M; Rico-Lattes, I. Drug Delivery by Soft Matter: Matrix and Vesicular Carriers. Angew. Chem. Int. Ed., (2009), 48, 274-288.
119. Gullotti, E; Yeo, Y. Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery. Mol. Pharmaceutics, (2009), 6, 1041-1051.
120. Singh, R; Lillard, JW. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., (2009), 86, 215-223.
121. Rosenholm, J M; Zhang J; Sun W. Large-pore mesoporous silica-coated magnetite core-shell nanocomposites and their relevance for biomedical applications. Micro Mes. Mat., (2011), 145, 14-20.
122. Min, X; Chen, C; Mingce, L. Magnetically separable mesoporous silica nanocomposite and its application in Fenton catalysis. Micro Mes. Mat., (2011), 145, 217-223.
123. Sen, T; Sebastianelli, A; Bruce, IJ. Mesoporous silica-magnetite nanocomposite: Fabrication and applications in magnetic bioseparations J. Am. Chem. Soc., (2006), 128, 7130-7131.
124. Kim, J; Kim, HS; Lee, N; Kim, T; Kim, H; Yu, T; Song, IC; Moon, WK; Hyeon, T. Multifunctional Uniform Nanoparticles Composed of a Magnetite Nanocrystal Core and a Mesoporous Silica Shell for Magnetic Resonance and Fluorescence Imaging and for Drug Delivery. Angew. Chem. Int. Ed., (2008), 47, 8438-8441.
125. Lin, YS; Haynes, CL. Synthesis and Characterization of Biocompatible and Size-Tunable Multifunctional Porous Silica Nanoparticles. Chem. Mater., (2009), 21, 3979-3986.
126. Mohamed, E; Hans, A; Hjalmar, G. Addition of silica nanoparticles to tailor the mechanical properties of nanofibrillated cellulose thin films. J. Colloid Interface Sci., (2011), 363, 566-572.
127. Rosenholm, JM; Zhang, J; Sun, W; Gu, H. Large-pore mesoporous silica-coated magnetite core-shell nanocomposites and their relevance for biomedical applications Micropor. Mesopor. Mat., (2011), 145, 14-20.
128. Xu, C; Xie, J; Ho, D; Wang, C; Kohler, N; Walsh, EG; Morgan, JR; Chin, JE; Sun, S. Au-Fe3O4 dumbbell nanoparticles as dual-functional probes. Angew. Chem. Int. Ed., (2008), 47, 173-176.
129. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer, (2007), 7, 573-584.
130. Wang, D; Lippard, SJ. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug. Discov., (2005), 4, 307-320.
131. Wainwright, M. Non-porphyrin photosensitizers in biomedicine. Chem. Soc. Rev., (1996), 25, 351-370.
132. Wainwright, M; Phoenix, DA; Marland, J; Wareing, DRA; Bolton, FJ. A study of photobactericidal activity in the phenothiazinium series. Med. Microbiol., (1997), 19, 75-80.
133. Schirmer, RH; Coulibaly, B; Stich, A; Scheiwein, M; Merkle, H; Eubel, J; Becker, K; Becher, H; Muller, O; Zich, T; Schiek, W; Kouyate, B. Methylene blue as an antimalarial agent. Redox Rep., (2003), 8, 272-275.
134. Lee, D; Foux, M; Leonard, EF. The effects of methylene blue and oxygen concentration on the photoinactivation of Q beta bacteriophage. Photochem. Photobiol., (1997), 65, 161-165.
135. Ohuigin, C.; McConnell, D. J.; Kelly, J. M.; Vanderputten, W. J. M. Methylene-blue photosensitized strand cleavage of DNA-effects of dye binding and oxygen. Nucleic Acids Res. (1987), 15, 7411-7427.
136. Wainwright, M. Pathogen inactivation in blood products. Current Med. Chem. (2002), 9, 127-143.
137. Schweitzer, C.; Schmidt, R. Physical mechanisms of generation and deactivation of singlet oxygen. Chem. Rev., (2003), 103, 1685-1757.
138. Crisostomo, A. G.; Moreno, R. B.; Navaratnam, S.; Wilkinson, J. A.; Bisby, R. H. Generation of superoxide and singlet oxygen from alpha-tocopherolquinone and analogues. Free Radical Res., (2007), 41, 730-737.
139. Bohne, C.; Faulhaber, K.; Giese, B.; Hafner, A.; Hofmann, A.; Ihmels, H.; Kohler, A. K.; Pera, S.; Schneider, F.; Sheepwash, M. A. L. Studies on the mechanism of the photo-induced DNA damage in the presence of acridizinium salts -Involvement of singlet oxygen and an unusual source for hydroxyl radicals. J. Am. Chem. Soc., (2005), 127, 76-85.
140. Wainwright, M.; Crossley, K. B. Photosensitising agents -circumventing resistance and breakingdownbiofilms: a review. Int. Biodeterioration Biodegrad., (2004), 53, 119-126.
141. Wainwright, M.; Phoenix, D. A.; Laycock, S. L.; Wareing, D. R. A.; Wright, P.A. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett., (1998), 160, 177-181.
142. Yaghini, E; Seifalian, AM; MacRobert, AJ. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomedicine, (2009), 4, 353-363.
143. Tada, DB; Vono, LLR; Duarte, EL; Itri, R; Kiyohara, PK; Baptista, MS; Rossi, LM. Methylene Blue-Containing Silica-Coated Magnetic Particles: A Potential Magnetic Carrier for Photodynamic Therapy. Langmuir, (2007), 23, 8194-8199.
144. Dougherty, TJ. Photosensitizers -Therapy and detection of malignant-tumors. Photochem. Photobiol., (1987), 45, 879-889.
145. Snyder, JW; Skovsen, E; Lambert, JDC; Ogilby, PRJ. Subcellular, time-resolved studies of singlet oxygen in single cells. J. Am. Chem. Soc., (2005), 127, 14558-14559.
146. Konan, YN; Gurny, R; Allémann, EJ. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B, (202), 66, 89-106.
147. Roby, A; Erdogan, S; Torchilin, VP. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur. J. Pharm. Biopharm., (2006), 62, 235-240.
148. Samia, ACS; Chen, XB; Burda, C. Semiconductor quantum dots for photodynamic therapy J. Am. Chem. Soc., (2003), 125, 15736-15737.
149. Bakalova, R; Ohba, H; Zhelev, Z; Nagase, T; Jose, R; Ishikawa, M; Baba, Y. Quantum dot anti-CD conjugates: Are they potential photosensitizers or potentiators of classical photosensitizing agents in photodynamic therapy of cancer. Nano Lett., (2004), 4, 1567-1573.
150. Andhariya, N; Chudasama, B; Mehta; Upadhyay, RV. Nanoengineering of methylene blue loaded silica encapsulated magnetite nanospheres and nanocapsules for photodynamic therapy J. Nanopart. Res., (2011), 13, 3619-3631.
151. Singer, AJ; Clark, RAF. Mechanisms of disease -Cutaneous wound healing. N. Engl. J. Med., (1999), 341, 738-746.
152. Seabra AB (2011). In: Ruy Beck, Adriana Pohlmann, Silvia Guterres. (Org.). Nanocosmetics and Nanomedicines, 1 ed. New York: Springer, v. 1, 253.
153. Lundblad, RJ; Bradshaw, RA; Gabriel, D; Ortel, TL; Lawson, J; Mann, KG. A review of the therapeutic uses of thrombin. Thromb. Haemost., (2004), 91, 851-860.
154. Tomasek, JJ; Gabbiani, G; Hinz, B; Chaponnier, C; Brown, RA. Myofibroblast and mechano-regulation of connective tissue remodeling. Mol. Cell. Biol., (2002), 3, 349-363.
155. Jesty, J. The kinetics of inhibition of alpha-thrombin in human plasma. J. Biol. Chem., (1986), 261, 10313-10318.
156. Smeets, R; Gerhards, F; Stein, J; Paz, RMP; Vogt, S; Pautke, C; Weitz, J; Kolk, A. Novel hemostatic delivery device for thrombin: Biodegradable poly(D, L -lactide-co-glycolide) 50:50 microspheres. J. Biomed. Mater. Res. Part A, (2011), 96A, 177-185.
157. Ziv-Polat, O; Topaz, M; Brosh, T; Margel, S. Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials, (2010), 31, 741-747.
158. Lanza, GM; Yu, X; Winter, PM; Abendschein, DR; Karukstis, KK; Scherrer, DE; Wickline, SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation, (2002), 106, 2842-2847.
159. Tan, AN; Bergheanu, SC; Stijnen, T; Plevier, JWM; Quax, PHA; Jukema JW. Clinical performance of drug-eluting stents with biodegradable polymeric coating: a metal-analysis and systematic review. Euro Interv., (2011), 7, 505-516.
160. Kempe, H; Kempe, M. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. Biomaterials, (2010), 31, 9499-9510.
161. Huang, L-Y; Yang, M-C. Behaviors of controlled drug release of magnetic-gelatin hydrogel coated stainless steel for drug-eluting-stents application. J. Magn. Magn. Mater. (2007), 310, 2874-2876.
162. Chulhyun, L; Lan, JS; Kyung, CM; Jee-Hyun, C; Ju, JE. Iron oxide nanoparticles as MRI contrast agents and their preparing method. Patent US 2011165086 (A1) (2011).
163. Malavosklish, B. Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof. International Patent WO 2010093420 (A2) (2010).
164. Persoons, A; Verbiest, T; Gangopadhyay, P. Targeted delivery of biologically active substances using iron oxide/gold core-shell nanoparticles. Patent GB 2415374 (A).
165. Ullate, PS; Martin, IG; Paramo, GJ; Penades, S; Galo, GIJ. Gold-coated nanoparticles, useful as e.g. detection agents, comprises magnetic core comprising metal-iron oxide, carbohydrates coupled to gold-coated nanoparticle, and immunoglobulin-binding protein coupled to gold-coated nanoparticle. International Patent WO20110361919 (A2) (2011).
166. Hultaman, K; Willis, A; ÓBrien, S; Brown, T; Harris, P; Turro, NJ; Grzenda, A. Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques. Patent US 2010-209352 (A1) (2010).
167. Zeng, Q; Baker, I. Iron/iron oxide nanoparticle and use thereof. Patente US 20110104073 (A1) (2011).
168. Chul, LM; Young, LS; Hoon, LS. Chondrocyte or synovium-derived stromal cell labeled with superparamagnetic iron-oide nanoparticles. Patent KR 20100113905 (A) (2010).
169. Namiki, Y; Kitamoto, Y; Fuchigami, T; Kawamura, R; Nakagawa, M. Magnetic particle-containing medicinal formulation useful for delivering drug, screening drugs, and separating and purifying nucleic acid, comprises hollow shaped magnetic particles, magnetic cage-shaped structure, and coating layer. Patent WO2011096230 (A1) (2011).
170. Gao, J; Fischler, M; Erdmann, VA. Drug delivery system, useful to treat e.g. bacterial infections, comprises composition-1 comprising nanoparticle associated with oligonucleotide inhibitor strand, and composition-2 comprising a carrier associated with substrate molecule. WO2011082796 (A2) (2011).
171. Yarowsky, P; Fishman, P; Puche, A; Shen, W. Targeting stem cells to specific region of individual affected with Parkinson's disease, by administering stem cells to individual and applying external source of magnetic field. Patent US 2011070202 (A1) (2011).
172. Mirkin, CA; Cutler, J.I. New nanoparticle containing an agent attached to a portion of nanoparticle surface through a triazolyl group, where agent has specific surface density, is useful for delivering agent to human cell to treat cancer. International Patent WO2011037973 (A1) (2011).
173. Burdinski, D; Pikkemaat, JA; Schmitt, B; Gruell, H; Langereis, S. Composition for controlled delivery of drug comprises shell structure forming cavity having drug and composition is associated with contrast agents containing magnetic particles having specific magnetic moment and composed of e.g. magnetite. International Patent WO2011001351 (A1) (2011).
174. Thiesen, B; Jordan, A. Implantable products comprising nanoparticles. Patent US 20110223255 (A1) (2011).
175. Weber, J., Atanasoska, L., Shippy, J.L., Scheuermann, T., Gregorich, D.J., Meyer, M.P. Endoprosthesis. Patent US 20110245905 (A1) (2011).